Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
              byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainIn the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for           
          
              
              Updated on: November 26,2024
              
              
                  
                  0              
              
              
          
      Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
              byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainIn the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for           
          
              
              Updated on:November 26,2024
              
              
                  
                  0              
              
              
          
      
					
      